These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 29220302)
1. Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives. Widemann BC; Italiano A J Clin Oncol; 2018 Jan; 36(2):160-167. PubMed ID: 29220302 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis, classification, and management of soft tissue sarcomas. Mankin HJ; Hornicek FJ Cancer Control; 2005; 12(1):5-21. PubMed ID: 15668648 [TBL] [Abstract][Full Text] [Related]
3. Soft tissue sarcomas. Spiguel A Cancer Treat Res; 2014; 162():203-23. PubMed ID: 25070237 [TBL] [Abstract][Full Text] [Related]
4. Pleomorphic Sarcomas: The State of the Art. Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults. Nascimento AF; Raut CP J Surg Oncol; 2008 Mar; 97(4):330-9. PubMed ID: 18286476 [TBL] [Abstract][Full Text] [Related]
6. The rare primary bone sarcomas: imaging-pathological correlation. Berkeley R; Andrei V; Saifuddin A Skeletal Radiol; 2021 Aug; 50(8):1491-1511. PubMed ID: 33410967 [TBL] [Abstract][Full Text] [Related]
7. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028 [TBL] [Abstract][Full Text] [Related]
8. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma. Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892 [TBL] [Abstract][Full Text] [Related]
9. [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma]. Meister P Pathologe; 2005 Mar; 26(2):127-33. PubMed ID: 15702318 [TBL] [Abstract][Full Text] [Related]
10. Management of adult soft-tissue sarcomas of the extremities. Simon MA; Spanier SS; Enneking WF Surg Annu; 1979; 11():363-402. PubMed ID: 228439 [No Abstract] [Full Text] [Related]
11. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status. Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298 [TBL] [Abstract][Full Text] [Related]
12. Malignant peripheral nerve sheath tumor: pathology and genetics. Thway K; Fisher C Ann Diagn Pathol; 2014 Apr; 18(2):109-16. PubMed ID: 24418643 [TBL] [Abstract][Full Text] [Related]
13. Fibroblastic Malignant Peripheral Nerve Sheath Tumour of the Uterine Cervix: Report of a Case and Literature Review With Emphasis on Possible Differential Diagnosis. Sangiorgio V; Zanagnolo V; Aletti G; Bocciolone L; Bruni S; Landoni F; Colombo N; Maggioni A; Ricciardi E Int J Gynecol Pathol; 2018 Sep; 37(5):497-503. PubMed ID: 29474318 [TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance. Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434 [TBL] [Abstract][Full Text] [Related]
15. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors. Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074 [TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology. Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630 [TBL] [Abstract][Full Text] [Related]
17. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas? Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499 [TBL] [Abstract][Full Text] [Related]
18. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification. Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423 [TBL] [Abstract][Full Text] [Related]